Fibrinolysis syndrome

Fibrinolysis syndrome
Fibrinolysis syndrome
Other names	Defibrinating syndrome

Fibrinolysis syndrome is characterized by an acute hemorrhagic state brought about by inability of the blood to clot, with massive hemorrhages into the skin producing blackish, purplish swellings and sloughing.^[1]^: 826

Symptoms

Hemorrhages (this includes severe bleeding of any particular area. Be it: nasal, rectal, oral, it also includes bleeding from scrapes, cuts, bruises (big bruises that do not disappear in the first two to three days).

Cause

The cause for Fibrinolysis syndrome, is the inability of the body to produce blood-coagulates to stop bleeding. What causes the body to not produce blood-coagulates are the low levels of fibrin, or therefore non-existent fibrin.^[2]

Diagnosis

Treatment

References

^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.
^ Merskey, C.; Johnson, A. J.; Kleiner, G. J.; Wom, H. (1967). "The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis". Department of Medicine and the American National Red Cross Research Laboratory. 13: 528. doi:10.1111/j.1365-2141.1967.tb00762.x. PMID 6029954. S2CID 20990370. Fibrin is a non-globular protein involved in the clotting of blood.

This cutaneous condition article is a stub. You can help Wikipedia by expanding it.

[Andrews-1] James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.

[Merskey-2] Merskey, C.; Johnson, A. J.; Kleiner, G. J.; Wom, H. (1967). "The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis". Department of Medicine and the American National Red Cross Research Laboratory. 13: 528. doi:10.1111/j.1365-2141.1967.tb00762.x. PMID 6029954. S2CID 20990370. Fibrin is a non-globular protein involved in the clotting of blood.

[1]

[2]